The need for the discovery and development of new pharmaceuticals for the treatment of cancer demands that all approaches to drug discovery should be exploited. Among the possible approaches, the one from natural products has made many unique and vital contributions to drug discovery. This mini review focuses on researches made in our laboratory on cycloartanes isolated from Parthenium argentatum, as well as some of its derivatives, in order to obtain potential anti-inflammatory and anti-cancer agents.
The term "Natural Products" generally refers to secondary metabolites (SMs), which are synthesized by secondary metabolism. For many years, plant secondary metabolism was neglected in science. Secondary metabolites were generally thought to be waste products, without apparent function [1] . Nowadays, their origin has been explained by diverse hypotheses, one of which proposes that this kind of metabolite plays a role in the survival of the organism by either providing defensive substances or other physiologically important compounds. In our context, one of the most important reasons to study SMs is that they indeed trigger very specific physiological responses, in many cases by binding to receptors with a remarkable complementarity [2] . It is known that natural product compounds have been an important source of several clinically useful anti-cancer agents. In 2000, approximately 53% of the compounds used in clinical trial as anti-tumor agents were either natural products or compounds derived from them, or designed from a natural product pharmacophore [3] .
The clinically important anti-cancer compounds include vinblastine, vincristine, the camptothecin derivatives, topotecan and irinotecan, etoposide, derived from epipodophyllotoxin, and paclitaxel (taxol®). Furthermore, diverse potential new anti-cancer compounds are in clinical development based on selective activity against cancer-related molecular targets, including flavopiridol and combretastin A4 phosphate [4] .
On the other hand, there are several kinds of natural products which are in preclinical development. One important group is constituted of triterpenes. For instance, betulinic acid, a SM isolated from several sources [5, 6] , is cytotoxic against several human cancer cell lines. It also showed antiangiogenic properties and significant in vivo activity in animal models bearing human melanoma xenografts. Ursolic acid and oleanolic acid, triterpenes widely distributed in the plant kingdom, are known for their anti-inflammatory and anti-cancer properties [7, 8] .
However, since they showed activities with low potencies, several analogs have been synthesized [9] . For example, 2-cyano-3,12-dioxoolean-1,9-dien-28oic acid (CDDO) and its methyl ester exhibit potent in vitro and in vivo anti-tumor activity against a wide range of tumors [10] .
Inflammation and Cancer
The perception that the inflammation process could be a cause of cancer is not new. In 1863, Virchow hypothesized that the origin of cancer was at sites of chronic inflammation, based on his hypothesis that some classes of irritants, together with the tissue injury and ensuing inflammation they cause, enhance cell proliferation. Although it is now clear that proliferation of cells alone does not cause cancer, sustained cell proliferation in an environment rich in inflammatory cells, growth factors, activated stroma, and DNA-damage-promoting agents certainly potentiates and/or promotes neoplasic risk. During tissue injury associated with wounding, cell proliferation is enhanced while the tissue regenerates; proliferation and inflammation subside either after the assaulting agent is removed or the repair is completed. In contrast, proliferating cells that sustain DNA damage and/or mutagenic assault (for example, initiated cells) continue to proliferate in microenvironments rich in inflammatory cells and growth/survival factors that support their growth. In a sense, tumors act as wounds that fail to heal [11] .
Although this proposal has been essentially unnoticed in the past, a growing body of evidence has recently indicated that the inflammatory process is a contributor, if not a cause, of a wide variety of neoplasms. Nowadays, it is recognized that at least 15% of tumors have a direct infectious origin. Generally, the pathogens that are responsible establish chronic infections that cause a persistent inflammatory response. Perhaps the best documented are the roles of Helicobacter pylori in stomach cancer, herpes viruses in cervical cancer and schistosomes in bladder cancers. Continuous irritants, such as asbestos, silica and cigarette smoke, also increase the probability of developing bronchial cancer. Colonic inflammation, such as that found in ulcerative colitis or Crohn's disease, predisposes sufferers to colorectal cancer. Indeed, even the prototypical oncogenic retrovirus, Rous sarcoma virus, requires an inflammatory response to induce tumors at secondary sites in chickens.
Even more, persistent infections within the host induce chronic inflammation. Leukocytes and other phagocytic cells induce DNA damage in proliferating cells through their generation of reactive oxygen and nitrogen species that are produced normally by these cells to fight infection. These species react to form peroxynitrite, a mutagenic agent [12] .
Altogether, the data show that inflammation creates a microenvironment that causes neoplasic transformation and potentiates the progression of cancers [13] . Therefore, either the inhibition or attenuation of inflammation processes could be helpful in cancer treatments.
In order to evaluate the anti-inflammatory activity of extracts and the SMs isolated from several plant species, our team used the in vivo TPA-induced edema model. Furthermore, it is known that tumor promoters like TPA not only set up an acute inflammatory response, but also cause alterations in cytokine signaling pathways that are required for the cancer development. Therefore, it is possible that compounds that showed anti-inflammatory effects on the TPA model could have either anti-proliferate or chemo-preventive effects. To support this proposal we have also determined the capability of several natural or derived substances to inhibit the growth of several human cancer cell lines. Taking that into account, we have made considerable efforts to find a correlation between the cytotoxic and anti-inflammatory properties of extracts of plant species growing in Mexico, the SMs isolated from them as well as some their derivatives [14] [15] [16] .
Parthenium argentatum
Parthenium argentatum is a bush that grows in the dry areas of northern México and southern USA. It is commonly known as guayule, which means "rubber tree".
The first paper dealing with the isolation of triterpenes from guayule was published in 1970 [17] . In this work, the isolation and structure elucidation of the cycloartane-type triterpenes argentatins A (1), B
(2) and C (3) were presented. However, the structures of argentatins B and C were later revised [18, 19] . From a n-hexane extract of roots of P. argentatum collected in the vicinity of Matehuala S.L.P. Mexico, a mixture of argentatin B (2) and isoargentatin B (5) was obtained. From this mixture, pure argentatin B was obtained by fractional crystallization from acetone; argentatin D (6) was also obtained, as were 1 and its isomer, incalinine (isoargentatin A) (4), which were isolated as a mixture that was resolved by fractional crystallization from acetone [20] .
The rubber obtained from guayule lies in its root, stem and branches; therefore it is necessary to process the entire bush to extract the rubber. Up to this moment, three methods of extraction are known, but the "flotation" method is the most financially attractive.
In this procedure, ground shrubs are placed in a large vat of dilute sodium hydroxide until the woody tissue takes-up water and sinks to the bottom. These worms are skimmed from the top and the rubber is deresinated with acetone. The acetone is then recovered by distillation, leaving the resin (la resina) as a remainder [21] .
Since the beginning it was thought that, to make the idea of guayule exploitation more attractive, the resin must have an economic benefit. Therefore, knowing the chemical constitution of this remainder was a priority [22] .
Our studies and others on the chemical composition of the resin showed that its main components are argentatins A (1) and B (2) . Furthermore, it is known that for each kilogram of natural rubber obtained, 1 kg of the resin by-product is also produced.
Considering that argentatins comprise 20% of the resin, it can be inferred that these compounds will be available in large amounts [17, 18, 20, 22, 23] .
Although the isolation of the argentatins from resin using chromatography columns packed with silica gel is a very well known process, in order to reduce costs, we have developed an alternative method using bentonite clay named "tonsil" as the stationary phase in the chromatography column. The yield of argentatins obtained is similar in both processes, although tonsil is several times cheaper than silica gel. The majority of our work on the chemistry and pharmacological studies was done with argentatins isolated from resin using tonsil.
As part of an effort to explore the structure-activity relationship of natural products isolated from guayule, and to confirm their elucidated structures, the X-ray crystal structure determination of incaniline (4) and argentatin B (2) were undertaken [18, 24] .
The isolation of argentatin C from the aerial parts of P. argentatum was reported in 1970; however, its structure was erroneously assigned. Due to an extensive study of its 1 H and 13 C NMR spectra, we propose that argentatin C could be depicted as 3, which was confirmed by an X-ray crystallographic study.
On the other hand, the structure of argentatin D (6) was elucidated by spectroscopic and chemical methods and confirmed by the X-ray crystallographic study of its acetate derivative [20] .
As a part of a program directed towards the synthesis and pharmacological and mass spectral properties of natural products, the electron impact mass spectrometry of the triterpenoids A (argentatin A type) and B (argentatin B type) was investigated in an attempt to determine whether their fragmentation patterns may be used for structural elucidation and, more importantly, to differentiate between these two types of triterpenoids [25] .
The results showed that the molecular ion of A easily loses the tetracyclic moiety of the triterpenoid skeleton to give the ion at m/z 143, the base peak for all the compounds A analyzed. It is the presence of this species that makes the identification of triterpenoids A relatively easy. On the other hand, the ion at m/z 143 easily loses water to give the fragment at m/z 125, which further loses a C 3 H 4 unit to yield the ion at m/z 85. There is also an ion at m/z [M-58] + . Such βcleavage of ethers and alcohols is well known and seems to be a more reasonable pathway for the formation of these ions.
As pointed out above, the resin is a potential source of chiral chemical substances that are suitable for transformation into triterpene-and steroid-like compounds with biological properties. In order to investigate the structure-activity properties of this type of compound we undertook the synthesis and spectral characterization of compounds 7-11 [26] . In this work, the stereo structures of 7 and 8 were determined by X-ray analysis. The introduction of the di-sodium salt (12) of carbenoxolone 3β-hydroxy-11-oxoolean-12-en-30oic acid 3-hemisuccinate as its di-sodium salt (12) as an antiulcer drug began in 1968. Since then, research on the carbenoxolane series has been active and has led to various modifications of the basic structure. In order to investigate structure-activity properties of carbenoxolone analogs and as a part of a program directed towards the synthesis of argentatin derivatives with possible pharmacological activities, The high structural similarities between 2 and the skeleton steroidal ring make this triterpene a suitable target for the rational design of potentially useful steroidal-like active molecules. Thus, our group has been preparing other argentatin derivates.
In this regard, the synthesis of some steroidal-like molecules has been reported with a pyrazole group fused to ring A, and which are currently used as antiinflammatory drugs. We then synthesized pyrazole derivatives of argentatin B in an attempt to pursue possible biologically active compounds. Our synthetic approach to prepare 30-35 involved a Claisen-Schmidt condensation of argentatin B with the respective 2-substituted benzaldehydes in a basic medium to give intermediates 18-23, and subsequent condensation with hydrazine to furnish 24-29. The final pyrazole derivatives 30-35 were obtained upon treatment of 24-29 with 2,3-dichloro-5,6-dycyano-1,4-benzoquinone [28] .
Anti-inflammatory and cytotoxic activities of argentatins and derivatives
Taking into account that several cycloartane triterpenoids had been reported as both antiinflammatory and cytotoxic agents [29] , we decided to evaluate the biological properties of some argentatins and to carry out the synthesis of some argentatin derivatives as the strategy to obtain structure-activity relationships and possible biologically-active compounds.
Argentatins A (1), B (2) and D (6) showed a doserelated anti-inflammatory activity and compound 2 was approximately 2-fold more potent than indomethacin, in the TPA-induced edema model. The 50% effective dose (ED 50 ) of argentatins is similar to those showed by other cycloartane triterpenes, such as cycloartenol (ED 50 = 0.3 mg/ear) [30] and 24-methylene-cycloartenol (ED 50 = 0.2 mg/ear). In order to gain some information about structureactivity relationships, we prepared fourteen derivatives from 1 and 2; compound 36, obtained from 1, was the most active derivative. Transformation of argentatins led us to determine that in the case for argentatin A, the presence of an acetyl group at C-16 and C-25, the oxidation of C-16, or the loss of the hydroxyl-isopropyl group led towards the formation of derivatives with significantly less activity. It can be inferred that the presence of alcohol groups at C-16 and C-25 are necessary for anti-inflammatory activity in most of the derivatives. However, as seen in 36, when the five-membered ring-E was opened, the presence of a carboxyl group seems important.
It is known that phorbol esters, such as TPA, can activate both phospholipid and Ca 2+ -dependent protein kinase C (PKC), an enzyme activated by endogenous diacylglycerol [31] . Therefore, it is possible that the anti-inflammatory activity showed by cycloartane triterpenes might be a consequence of either binding interactions with nuclear receptors or inhibition of PKC activity; however, the elucidation of the mechanism of action is necessary.
The role of hormone therapy is to block, at least in part, the action of estrogens. It is based on the use of anti-estrogens, which compete with stradiol for the active site of the receptor. In view of the clinical importance of hormone therapy, our interest has been focused on the use of compounds with similar structures to those of the steroid hormones. Therefore, we decided to study the effect of various concentrations of 1, 2 and 6 on their interactions with the estrogen-receptor.
The degree of binding of argentatin A, B and D to the cytoplasmic receptors was estimated from the incorporation of 3 H-estradiol to cytosol from the estrogen-dependent tumors [32] . The specific union values for cytosolic receptors to estradiol, calculated previously by the method of Scatchard, were in the range of 300625 f mol mg -1 protein.
Argentatin A, B and D showed 45%, 85% and 40% inhibition, respectively. This diminution in the specific estrogen-binding capacity was timetemperature and concentration-dependent.
No increments in either the binding capacity or affinity to the estrogen binding assays were observed when the argentatins were added after overnight incubation.
The nature of the inhibitory effect of argentatin B in the cytosol of hormone-dependent tumors was studied by Lineweaver-Burk analysis.
Increasing concentrations of 3 H-estradiol were incubated with cytosol of hormone-dependent tumors in either the presence or absence of fixed concentrations (20 or 50 nM) of argentatin B. Argentatin B was clearly a non competitive inhibitor of 3 H-estradiol binding.
The relative binding affinities of 1, 2 and 6 for the estrogen receptor suggest that these compounds antagonize the action of estrogens in the receptor of hormone-dependent tumors by non-competitive inhibition. These indicate that the action mechanism of argentatins A, B and D is not via an active site estradiol-receptor system. These results also suggest the existence of binding sites for other natural ligands, to which the terpenoid compounds bear a structural resemblance [32] .
Since, some cycloartane-type triterpenes, such as methyl quadrangularates B (37) and D (38) , have shown cytotoxic activity on carcinoma cells [33] [34] [35] , we decided to evaluate the cytotoxic activity of argentatins A and B on PC-3, U251, MCF-7, HCT-15 and K562 human cancer cell lines in the sulforhodamine B (SRB) test. Many of the cytotoxic triterpenoids described in the literature seem to exert their activity by interfering with DNA replication, typically by inhibition of either DNA polymerase or topoisomerase. For instance, betulinic, ursolic, and oleanolic acids show inhibition of DNA polymerase β, as well as inhibition of topoisomerases I and II [37, 38, [40] [41] [42] [43] [44] .
As a strategy to elucidate structural requirements involved in the cytotoxic activity of argentatin A, we synthesized nine derivatives of argentatin A (39-47). These compounds were assessed according to their ability to inhibit growth in vitro in four human cancer cell lines.
Our results showed that the presence of either a double bond at C-1/C-2 (40), or a bromine atom (39) or formyl moiety at C-2 (46), as well as the presence of an isoxazol ring (47) in argentatin A, (2) enhanced its potency in all cell lines tested (table 1) . As for anti-inflammatory actions, the loss of the hydroxyisopropyl group led to an inactive derivative, which seems to indicate that the function is essential for both activities.
In addition, an X-ray study of (16S, 17R, 20S, 24R)-3-oxime-20,24-epoxy-16,25-dihydroxy-cycloartan-3-one (42) led to the determination of the correct stereochemistry of argentatin A as (16S, 17R, 20S, 24R)-20,24-epoxy-16,25-dihydroxy-cycloartan-3-one [45] .
On the other hand, it is known that some antineoplastic agents, such as doxorubicin, cisplatin and mitomycin, in addition to their cytotoxic effect, have important adverse effects such as genotoxicity. These effects have been determined using several in vitro systems, such as the cytokinesis-block micronucleus (CBMN) assay.
Considering that the CBMN assay allows us to evaluate genotoxic as well as cytostatic effects, it was decided to use it to evaluate these effects of 1 and 2.
The cytotoxic and cytostatic effects of argentatins A and B on proliferating lymphocytes were evaluated using percentage of cell viability, Cell Proliferation Kinetics (CPK) and Nuclear Division Index (NDI). These parameters allowed us to differentiate between cell death and cytostatic effects by delaying any phase of the cell cycle [46, 47] .
Our results demonstrated that argentatin A (1) reduced cell survival at 25 μM, and it is not a cytostatic compound. On the other hand, argentatin B (2) showed no effects on cell viability at the tested concentrations, but it decreased the cell proliferation and Nuclear Division Index (NDI). The cytostatic effects in terms of the NDI shown by this compound (at 25 μM) and mitomycin C (1 μM) were not significantly different, although a different potency was observed.
Neither argentatin A nor B showed genotoxic effects in terms of increasing micronucleus frequency; this fact suggested that these compounds are not able to cause injury to DNA by either clastogenic or aneugenic mechanisms [36] .
In order to gain an insight into the structural requirements for the inhibitory activity of argentatin B (2), we synthesized and tested the growth inhibition of fourteen analogs (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) in four human cancer cell lines: K562 (leukemia), PC-3 (prostate), U251 (CNS), and HCT-15 (colon).
Comparative molecular field analysis (CoMFA) was employed to analyze the quantitative structureactivity relationships of the set of argentatin B analogs [48] . All 14 derivatives were characterized by spectroscopic and analytical tools. Additionally, the structures of 49, 51, 58 and 59 were confirmed by X-ray studies.
Preliminary structure-activity relationship observations of the cytotoxicity results showed that a bromine atom substitution at C-2 48 enhanced the potency of 2 in three cell lines: HCT-15, K562 and PC-3. The cyano substitution at C-2 59, improved the cytotoxicity of 2 and 48 in all cell lines; however, 60 was selectively cytotoxic for PC-3 and U251 cell lines showing stronger activity in U251 CNS cancer cells. Compound 49, a C-1/C-2 unsaturated derivative with an additional formyl substituent at C-2, had a strength 35 to 50 fold higher than 2 and was the most potent analog in the series. A fused C-2/C-3 isoxazol ring decreased the cytotoxicity of 2 in all cell lines. The lactone derivative 61 was inactive, suggesting that the presence of an isopropyl alcohol group at C-24 is essential for activity.
The biological data for the K562 cell line was used as a dependent variable in a comparative molecular field analysis (CoMFA).
The standard deviation contours associated with the inhibitory potency of the series produced a relatively large sterically favorable region at C-2, a small negative contour between C-2 and C-3, and, in addition, two smaller negative contours just below the ring.
A CoMFA electrostatic standard deviation map shows a big polyhedral surface surrounding atoms C-1 and C-2, indicating that low electronic density at these positions improves the cytotoxic activity. This region corresponds to the decreased electronic density at the α,β-unsaturated carbonyls in 49 and 58; in analogs 48, 57 and 59, with electron-withdrawing groups at C-2, all are more active than 2.
These results showed that the potency of these triterpenes against K562 increases with bulky substituents at C-2, a C1-C2 double bond, and low electronic density near C-26 and C-27 [48] .
Conclusions
We have demonstrated that natural argentatins show several biological effects and that these compounds are not genotoxic to human lymphocytes. Furthermore, several potential derivatives with anti-inflammatory and/or cytotoxic activity were synthesized and some structure-activity relationships were investigated. Although there are some features in common when comparing the anti-inflammatory and cytotoxic activities shown by a specific derivative, it was observed that chemical transformations were able to modify the cytotoxic activity principally.
It is possible that some biological effects shown by argentatins, at least in part, are connected with their capability to inhibit some specific receptors, such as the estrogen-receptor system; however, it is necessary to determine what are the mechanisms involved.
Our studies suggest the existence of binding sites for other natural ligands, to which the terpenoid compounds bear a structural resemblance.
